Skip to main content
. Author manuscript; available in PMC: 2021 Dec 30.
Published in final edited form as: Am J Transplant. 2020 Mar 12;20(8):2101–2112. doi: 10.1111/ajt.15825

TABLE 4.

Three-year cumulative incidence of overall transplant for highly sensitized candidates by era and cPRA1

cPRA Era 1 Era 2 Era 3
80%-89% 48.5 50.2 46.2
90%-97% 32.0 34.1 47.9
98%-99.9% 13.1 16.5 50.1
99.9%+ 5.2 5.1 27.0

Note: Over time, there was a substantial increase in the percentage of cPRA 90%+ candidates receiving a transplant by 3 y after listing. For example, 50.1% of cPRA 98%−99.9% candidates received a transplant within 3 y in Era 3, compared to 13.1% in Era 1.

Abbreviation: cPRA, calculated panel reactive antibody.

1Includes all modalities (ie, deceased donor kidney transplantation and overall living donor kidney transplantation).